NCPA Updates--May 2009

Published Online: Thursday, May 7, 2009

Make Health Care Reform Work for You and Your Patients!
NCPA's Annual Conference on National Legislation and Government Affairs is shaping up to be one of the best and most important ever. Hear from speakers and others addressing our key legislative issues: health care reform, a Medicaid AMP fix, DME accreditation, and PBM business negotiation rights. Please note this year’s schedule: The conference begins at noon on Monday, May 11, and concludes with a pharmacist rally on Wednesday morning, May 13. The Congressional Reception is now Tuesday evening. Get involved! Register today!

Discounts on Employee Background Screening
If you are seeking DME accreditation and the accrediting organization recommends background screening for staff, remember that NCPA offers exclusive members discounts on employee background screening services from the investigative consultants firm of Pedersen & Associates. For more information, e-mail Valerie Briggs.

NCPA Members Forum Series
Have you missed the NCPA Members Forum Series? To date, nearly 500 pharmacists have dialed in to the new members–only live discussions on DME accreditation, small business tax provisions, pharmacy security, health information technology, and the new NCPA Prescription Disposal Program. For more information about recordings and materials from previous calls, e-mail Valerie Briggs.

Latest Articles
Mylan has announced the US launch of clozapine orally disintegrating tablets, 25 mg and 100 mg, the generic version of Jazz Pharmaceutical’s FazaClo.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about some safeguards pharmacists can implement.
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Latest Issues